Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06299553
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-02-22
Brief Title:
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy PRO-MIND
Sponsor:
Organization:
Incyte Biosciences Italy Srl